Back to GetFilings.com



 

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

ý  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934.

 

For the quarterly period ended March 31, 2003

 

o  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934

 

For the transition period from              to             .

 

Commission File Number 0-21221

 

MICROVISION, INC.

 (Exact Name of Registrant as Specified in Its Charter)

 

Washington

 

91-1600822

(State or Other Jurisdiction of Incorporation
or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

19910 North Creek Parkway, Bothell, Washington

 

98011-3008

(Address of Principal Executive Offices)

 

(Zip Code)

 

 

 

Registrant’s telephone number, including area code: (425) 415-6847

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ý Yes   o No

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). o Yes   ý No

 

As of April 30, 2003, 17,799,000 shares of the Company’s common stock, no par value, were outstanding.

 

 



 

PART I

FINANCIAL INFORMATION

 

Item 1 -

Financial Statements (unaudited)

 

 

 

Consolidated Balance Sheets as of March 31, 2003 and December 31, 2002

 

 

 

Consolidated Statements of Operations for the three months ended March 31, 2003 and 2002

 

 

 

Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2003 and 2002

 

 

 

Consolidated Statements of Cash Flows for the three months ended March 31, 2003 and 2002

 

 

 

Notes to Consolidated Financial Statements

 

 

Item 2 -

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

Item 3 -

Quantitative and Qualitative Disclosures About Market Risk

 

 

Item 4 –

Controls and Procedures

 

 

PART II

OTHER INFORMATION

 

Item 6 -

Exhibits and Reports on Form 8-K

 

2



 

Microvision, Inc.

 

Consolidated Balance Sheet

(In thousands)

 

 

 

March 31,
2003

 

December 31,
2002

 

 

 

(Unaudited)

 

 

 

Assets

 

 

 

 

 

Current Assets

 

 

 

 

 

Cash and cash equivalents

 

$

16,911

 

$

9,872

 

Investment securities, available-for-sale

 

3,037

 

5,304

 

Accounts receivable, net of allowances of $109 and $109

 

2,013

 

1,315

 

Costs and estimated earnings in excess of billings on uncompleted contracts

 

955

 

1,073

 

Inventory, net

 

244

 

747

 

Other current assets

 

2,134

 

2,348

 

Total current assets

 

25,294

 

20,659

 

 

 

 

 

 

 

Property and equipment, net

 

7,077

 

7,672

 

Restricted investments

 

1,297

 

1,356

 

Receivables from related parties, net

 

1,843

 

2,043

 

Other assets

 

392

 

537

 

Total assets

 

$

35,903

 

$

32,267

 

 

 

 

 

 

 

Liabilities, Minority Interests and Shareholders’ Equity

 

 

 

 

 

Current Liabilities

 

 

 

 

 

Accounts payable

 

$

1,576

 

$

1,462

 

Accrued liabilities

 

5,011

 

4,309

 

Billings in excess of costs and estimated earnings on uncompleted contracts

 

184

 

230

 

Current portion of capital lease obligations

 

79

 

84

 

Current portion of long-term debt

 

65

 

63

 

Total current liabilities

 

6,915

 

6,148

 

 

 

 

 

 

 

Research liability

 

1,477

 

1,025

 

Capital lease obligations, net of current portion

 

73

 

94

 

Long-term debt, net of current portion

 

152

 

169

 

Deferred rent, net of current portion

 

170

 

192

 

Total liabilities

 

8,787

 

7,628

 

 

 

 

 

 

 

Commitments and Contingencies

 

 

 

 

 

 

 

 

 

Minority Interests

 

5,334

 

7,223

 

 

 

 

 

 

 

Shareholders’ Equity

 

 

 

 

 

Common stock and paid-in capital, no par value, 31,250 shares authorized; 17,799 and 15,154 shares issued and outstanding

 

158,644

 

147,058

 

Deferred compensation

 

(1,273

)

(1,490

)

Subscriptions receivable from related parties

 

(166

)

(166

)

Accumulated other comprehensive income

 

80

 

121

 

Accumulated deficit

 

(135,503

)

(128,107

)

Total shareholders’ equity

 

21,782

 

17,416

 

Total liabilities, minority interests and shareholders’ equity

 

$

35,903

 

$

32,267

 

 

The accompanying notes are an integral part of these financial statements.

 

3



 

Microvision, Inc.

 

Consolidated Statement of Operations

(In thousands, except earnings per share data)

(Unaudited)

 

 

 

Three months ended March 31,

 

 

 

2003

 

2002

 

 

 

 

 

 

 

Revenue

 

$

3,537

 

$

3,804

 

 

 

 

 

 

 

Cost of revenue

 

1,409

 

1,811

 

Gross margin

 

2,128

 

1,993

 

 

 

 

 

 

 

Research and development expense (exclusive of non-cash compensation expense of $251 and $256 for the three months ended March 31, 2003 and 2002, respectively)

 

6,800

 

7,369

 

 

 

 

 

 

 

Marketing, general and administrative expense (exclusive of non-cash compensation expense of $214 and $259 for the three months ended March 31, 2003 and 2002, respectively)

 

4,285

 

4,509

 

 

 

 

 

 

 

Non-cash compensation expense

 

465

 

515

 

Total operating expenses

 

11,550

 

12,393

 

 

 

 

 

 

 

Loss from operations

 

(9,422

)

(10,400

)

 

 

 

 

 

 

Interest income

 

123

 

338

 

Interest expense

 

(14

)

(18

)

Realized gain on sale of investment securities

 

27

 

 

 

 

 

 

 

 

Loss before minority interests

 

(9,286

)

(10,080

)